Lee J-M - Women’s Malignancies Branch, National Cancer Institute

基本信息

浏览量：15

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 190 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Impact of Global Enrollment on Race, Ethnicity, and Age Representation in Pivotal Gynecologic Cancer Trials Leading to US Food and Drug Administration Drug Approvals

Maheen H Khan, Kristen R Ibanez, Courtney Bowen,Duncan Donohue,Ann Oluloro, Elizabeth M Swisher,Jung-Min Lee

JCO global oncology (2025): e2400636-e2400636

引用0浏览0WOS引用

Reduced-intensity Chemotherapy with Tyrosine Kinase Inhibitor Followed by Allogeneic Transplantation is Effective in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Jung Min Lee,Do Young Kim,Hee Jeong Cho,Joon Ho Moon,Sang Kyun Sohn,Ho Jin Shin,Young Rok Do,Mi Hwa Heo,Min Kyoung Kim, Young Seob Park,Dong Won Baek

KOREAN JOURNAL OF INTERNAL MEDICINEno. 1 (2025)

引用0浏览0WOS引用

Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: the Phase II NRG-GY023 Trial

Jung-Min Lee,Austin Miller,Peter G Rose, Mariam AlHilli,Christina Washington, Veena S John, Chirag A Shah,Koji Matsuo,Jean Siedel,David S Miller, Elizabeth E Hopp, Andrea O'Shea,John K Chan, Leslie S Bradford, Christopher B Morse, Christa I Nagel, Kerry J Rodabaugh,Elise C Kohn,Kathleen N Moore,Joyce F Liu

Clinical cancer research an official journal of the American Association for Cancer Research（2025）

引用0浏览0WOS引用

Comparison of Oncological Outcomes of Premenopausal with Ovarian Function Suppression Versus Postmenopausal Women in ER+/HER2- Breast Cancer

Min Jung Lee, Jung, Jong-Ho Cheun,Eunhye Kang,Hong-Kyu Kim, Han-Byoel Lee,Hyeong-Gon Moon,Wonshik Han

Breast (Edinburgh, Scotland)（2025）

引用0浏览0WOS引用

Topoisomerase IIIβ Protects from Tumorigenesis and Immune Dysregulation

Rasel Al Mahmud, Simone Andrea Baechler, Anjali Dhall, Sourav Saha,Hongliang Zhang,Shuling Zhang,Min-Jung Lee,Nahoko Sato, Shraddha Rastogi,Suresh Kumar, Muhammad S Alam, Liton Kumar Saha,Beverly A Mock,Valentina M Factor,Yves Pommier

bioRxiv the preprint server for biology (2025)

引用0浏览0WOS引用

PARP Inhibitors in Ovarian Cancer

Ian S. Goldlust, Elena Guidice,Jung-min Lee

Seminars in Oncologyno. 1-2 (2024): 45-57

引用38浏览0WOS引用

A Phase II/III Study of Cediranib and Olaparib Combination Compared to Cediranib or Olaparib Alone or Standard of Care Chemotherapy, in Platinum-Resistant Ovarian Cancer (NRG-GY005)

Jung-Min Lee, Brady Mark,Austin Miller,Richard Moore,Helen Mackay,Leah McNally,Jayanthi Lea, Daron Street,Stephanie Lheureux,David Bender,Linda Duska,Guilherme Cantuaria,Juraj Kavecansky,Charles Leath,Matthew Powell, Mark Cadungog, Peter Rose,Michael Bookman,Elise Kohn,Angeles Alvarez Secord

GYNECOLOGIC ONCOLOGY (2024): S13-S13

引用0浏览0引用

Gynecologic Cancer InterGroup CA125 Response Has a High Negative Predictive Value for CHK1 Inhibitor RECIST Response in Recurrent Ovarian Cancer

Kristen R. Ibanez,Duncan Donohue,Tyler Malys,Jung-Min Lee

Scientific Reportsno. 1 (2024)

引用0浏览0WOS引用

Supplementary Fig. S4 from AKT1 Interacts with DHX9 to Mitigate R Loop–Induced Replication Stress in Ovarian Cancer

Tzu-Ting Huang,Chih-Yuan Chiang,Jayakumar R. Nair,Kelli M. Wilson,Ken Cheng,Jung-Min Lee

crossref（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn